Try our mobile app

Published: 2023-07-28 18:02:42 ET
<<<  go to BAK company page
6-K 1 bak20230728_6k2.htm 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of July, 2023

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

 

DETAILED FINAL VOTING MAP

EXTRAORDINARY GENERAL MEETING

HELD ON JULY 28, 2023

 

São Paulo, July 28, 2023 – Braskem S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) (“Company”), in compliance with CVM Resolution No. 81/22, as amended, hereby disclose to its shareholders and the market the detailed final voting map which consolidates the voting instructions of both shareholders which voted through remote voting (boletim de voto a distância) and those during the Meeting, as computed at the Extraordinary General Meeting of the Company held on July 28, 2023, including the first five digits of the shareholders’ individual or corporate taxpayer identification number (CPF or CNPJ, respectively), their vote on each item, and information about their shareholding position, as EXHIBIT I.

Further information can be obtained from Braskem’s Investor Relations Department by phone: +55 (11) 3576-9531 or by e-mail: braskem-ri@braskem.com.br

 

 

 

 
 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

EXHIBIT I

DETAILED FINAL VOTING MAP

EXTRAORDINARY GENERAL MEETING

HELD ON JULY 28, 2023

 

Resolutions
1 Approval of the Company’s new Long Term Incentive Plan, as per managements proposal.
2

Separate election of an alternate member of the Company’s Fiscal Council by holders of non-voting preferred shares or with restricted voting rights

Paulo Roberto Bellantani Brandão

 

 
 

 

Description of the Resolution CNPJ/CPF
(first 5 digits)
Resolution Vote Numbers of Shares
(ON)¹ (PN)²
Extraordinary General Meeting
1 33000 APROVAL 212,426,952 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 REJECTION 4,600,000 -
44364 REJECTION 5,000 -
2 55237 APROVAL - 22,196,502
55237 REJECTION - 87,194
55237 ABSTENTION - 827,484
89351 APROVAL - 16,491,800
40147 APROVAL - 21,916
23127 APROVAL - 426,088
21407 APROVAL - 352,617
11184 APROVAL - 1,673
13416 APROVAL - 36,830
12984 APROVAL - 8,278
70965 APROVAL - 5,925
20147 APROVAL - 81,566
76866 APROVAL - 2,112
18138 APROVAL - 18,976
10263 APROVAL - 56,831
28872 APROVAL - 24,764
60699 APROVAL - 15,061
37347 APROVAL - 91,394
19388 APROVAL - 47,096
33700 APROVAL - 93,307
14416 APROVAL - 82,581
42332 APROVAL - 21,975
47518 APROVAL - 23,856
35726 APROVAL - 11,700
39332 APROVAL - 97
44364 APROVAL - 5,500
54791 APROVAL - 333,800
54797 APROVAL - 306,613
58387 APROVAL - 24,477
58390 APROVAL - 27,070
58390 APROVAL - 120,467
58392 APROVAL - 3,000
58394 APROVAL - 161,955
58396 APROVAL - 10,261,142
58397 APROVAL - -

 

 
 

 

  58399 APROVAL - 22,754
58400 APROVAL - 28,900
58400 APROVAL - 202,239
58401 APROVAL - 440,710
59868 APROVAL - 2,300
59871 APROVAL - 142,335
59873 APROVAL - 1,547
59874 APROVAL - 54,177
62390 APROVAL - 229,719
71409 APROVAL - 181,638
72087 APROVAL - 14,100
72372 APROVAL - 257,108
72473 APROVAL - 41,200
74963 APROVAL - 30,700
74963 APROVAL - 121,162
75166 APROVAL - 8,464
78892 APROVAL - 40,900
87318 APROVAL - 3,500
87889 APROVAL - -
90633 APROVAL - 343,109
91457 APROVAL - 1,055,698
94700 APROVAL - 7,700
95596 APROVAL - 96,180
96275 APROVAL - 178,776
10205 APROVAL - 351
10263 APROVAL - 25,721
10492 APROVAL - 542,363
10916 APROVAL - 241,103
11100 APROVAL - 261,001
11311 APROVAL - 114,081
11324 APROVAL - 7,300
11458 APROVAL - 17,436
11729 APROVAL - 16,400
12094 APROVAL - 45,900
12120 APROVAL - 48,400
13562 APROVAL - 183,937
14204 APROVAL - 94,766
14258 APROVAL - 41
14494 APROVAL - 8,451
14541 APROVAL - 104,200
14588 APROVAL - -
16878 APROVAL - 4,900
17718 APROVAL - 339,377
17797 APROVAL - 162,823

 

 
 
  18407 APROVAL - 139,377
18830 APROVAL - 2,800
19530 APROVAL - 5,938
20813 APROVAL - 271,140
20849 APROVAL - 600
21477 APROVAL - 242,688
22360 APROVAL - 7,800
22403 APROVAL -  89,695
22410 APROVAL - 352,505
22420 APROVAL - 71,740
23041 APROVAL - 23,857
23442 APROVAL - 19,562
23847 APROVAL - -   
23847 APROVAL - 115,000
24569 APROVAL - 931
24676 APROVAL - 133,928
24849 APROVAL - 247,527
25271 APROVAL - 14,402
25271 APROVAL - 32,070
26160 APROVAL - 4,100
26301 APROVAL - 58,100
26311 APROVAL - 4,100
26431 APROVAL - 235,769
26784 APROVAL - 3,600
27222 APROVAL - 12,020
27624 APROVAL - 27,143
27714 APROVAL - 91,095
27778 APROVAL - 21,590
27866 APROVAL - 9,427
27866 APROVAL - 29,764
27866 APROVAL - 21,635
27866 APROVAL - 10,122
27866 APROVAL - 41,686
27866 APROVAL - 1,961
28038 APROVAL - 99,272
28394 APROVAL - 14,300
28979 APROVAL - 100
28990 APROVAL - 57,600
29322 APROVAL - 1,887,969
30066 APROVAL - 70,472
30254 APROVAL - 14,994
30855 APROVAL - 8,100
30855 APROVAL - 16,800
31477 APROVAL - 57,338

 
 
  31577 APROVAL - 16,800
31751 APROVAL - 406,429
31914 APROVAL - 2,600
32106 APROVAL - 2,750
32329 APROVAL - 109,836
33580 APROVAL - 10,700
33968 APROVAL - 18,810
34825 APROVAL - 765
35693 APROVAL -    1,133,500
36018 APROVAL - 66,817
37259 APROVAL -    1,699,127
37806 APROVAL - 1,513
38756 APROVAL - 20,000
41063 APROVAL - 30,000
41222 APROVAL - 66,800
41286 APROVAL - 22,284
41941 APROVAL - 1,113
42887 APROVAL - 600
43068 APROVAL - 305,380
43105 APROVAL - 96,124
44602 APROVAL - 3,294
45919 APROVAL - 60,159
46964 APROVAL - 4,900
46981 APROVAL - 1,006
48123 APROVAL - 4,070
48429 APROVAL - 2,100
49444 APROVAL - 13,992
97539 APROVAL - 287,214
97539 APROVAL - 202,738
97540 APROVAL - 466,164
97540 APROVAL - 214,096
97540 APROVAL - 2,134,883

 

(1) ON shares are common shares issued by the Company. It does not take into consideration Treasury Stock.

(2) PN shares are class A preferred shares issued by the Company, which have voting rights solely and exclusively in the resolution for the election of an alternate member of the Fiscal Council to replace the member elected separately at the Annual and Extraordinary General Meeting held on April 26, 2023, pursuant to article 161, paragraph 4, item “a” of the Brazilian Corporate Law. Does not consider shares held in treasury.

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 28, 2023

  BRASKEM S.A.
       
       
  By:      /s/     Pedro van Langendonck Teixeira de Freitas
     
    Name: Pedro van Langendonck Teixeira de Freitas
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.